Progress in peanut-allergy immunotherapy
As immunotherapy for peanut allergy advances, a Stanford allergy expert discusses what that means for parents, providers and the future of allergy treatments.
The basics of acute flaccid myelitis
Small clusters of cases of infectious paralysis are occurring in young children across North America. A Stanford pediatric neurologist is working to understand the disease.
What to know about concussions
Angela Lumba-Brown, MD, co-director of the Stanford Concussion and Brain Performance Center, is the lead author of the newly published CDC Guidelines on the Management of Mild Traumatic Brain Injury in Children. In a recent interview, she explained what families should know about concussions.
Innovations in kids’ MRI scans
Stanford pediatric radiologist Shreyas Vasanawala is tailoring MRI equipment to children. His work allows young patients to receive faster MRI exams that require less anesthesia.
Zulman on engaging high-need patients
Patient engagement requires creativity, trust building and flexibility from health care providers, especially when treating high-need patients, a new Stanford study says.
New therapy for drug-resistant epilepsy
The FDA has approved the use of an implanted device that releases periodic electrical discharges in the brain to counteract seizures in people with epilepsy. In an interview, neurologist Robert Fisher described the technology and Stanford’s role in testing the device.
Ioannidis on nutrition research
Stanford's John Ioannidis recently discussed why the design of most nutrition studies impedes progress in the field and suggested a new kind of approach.
How border separations can traumatize kids
Unplanned separation from parents is among the most damaging events a young child can experience, according to trauma research. A Stanford expert explains how it can hurt kids’ development.
IUD device aids contraception in India
Stanford researchers and their colleagues have tested a new contraceptive device that they say could provide broader access to long-acting contraception in developing countries.
Could Nipah virus become global pandemic?
Stephen Luby discusses risk factors and potential interventions for Nipah virus, a disease with no vaccine and a mortality rate of up to 70 percent.
Leading in Precision Health
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.